Benitec Biopharma (BNTC) Retained Earnings (2019 - 2025)
Benitec Biopharma (BNTC) reported Retained Earnings of -$883000.0 for Q4 2025, down 28.34% on a YoY basis from -$1.2 million in Q4 2024, and up 99.63% sequentially from -$237.1 million in Q3 2025.
Benitec Biopharma (BNTC) Retained Earnings (2019 - 2025) Analysis & Trends
Benitec Biopharma (BNTC) has 7 years of Retained Earnings data on file, last reported at -$883000.0 in Q4 2025.
- For the quarter ending Q4 2025, Retained Earnings fell 28.34% year-over-year to -$883000.0; the trailing twelve-month figure through Dec 2025 stood at -$883000.0 (down 28.34% YoY), and the FY2025 full-year result was -$839000.0, up 99.56% from the prior year.
- Retained Earnings climbed to -$883000.0 in Q4 2025, from -$237.1 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$688000.0 in Q4 2024 to a low of -$237.1 million in Q3 2025.
- A 5-year average of -$96.8 million and a median of -$136.7 million in 2021 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings tumbled 23539.84% in 2023 and jumped 99.62% in 2024, its largest moves.
- Tracing BNTC's Retained Earnings over 5 years: stood at -$1.3 million in 2021, then tumbled by 12376.9% to -$158.8 million in 2022, then decreased by 14.12% to -$181.3 million in 2023, then jumped by 99.62% to -$688000.0 in 2024, then dropped by 28.34% to -$883000.0 in 2025.
- Business Quant data shows BNTC's Retained Earnings at -$883000.0 in Q4 2025, -$237.1 million in Q3 2025, and -$839000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Benitec Biopharma | 46.45 Mn | 46.45 Mn | - | -883,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -883,000.00 |
| Sep 30, 2025 | -237.14 Mn |
| Jun 30, 2025 | -839,000.00 |
| Mar 31, 2025 | -716,000.00 |
| Dec 31, 2024 | -688,000.00 |
| Sep 30, 2024 | -195.32 Mn |
| Jun 30, 2024 | -190.26 Mn |
| Mar 31, 2024 | -185.54 Mn |
| Dec 31, 2023 | -181.26 Mn |
| Sep 30, 2023 | -174.46 Mn |
| Jun 30, 2023 | -167.89 Mn |
| Mar 31, 2023 | -163.23 Mn |
| Dec 31, 2022 | -158.83 Mn |
| Sep 30, 2022 | -738,000.00 |
| Jun 30, 2022 | -1.25 Mn |
| Mar 31, 2022 | -143.26 Mn |
| Dec 31, 2021 | -1.27 Mn |
| Sep 30, 2021 | -1.22 Mn |
| Jun 30, 2021 | -130.12 Mn |
| Mar 31, 2021 | -1.59 Mn |